Dimensional Fund Advisors’s Aardvark Therapeutics AARD Stock Holding History

Dimensional Fund Advisors’s Portfolio AARD Stock Details AARD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$93.3K	Buy	+17,710	New	+$108K	﹤0.01%	3139

Other funds holding AARD

Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return

Stone House Investment Management Tunkhannock, Pennsylvania $768M AUM 12.07% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Dimensional Fund Advisors's AARD Position: Q3 2026 in Review

Dimensional Fund Advisors opened a new position in Aardvark Therapeutics (AARD) in Q3 2026: 17,710 shares worth $93.3K. The stake represents ﹤0.01% of the portfolio and ranks #3139 among its holdings.

23 funds tracked by Wall St. Rank hold AARD as of Q3 2026.

Dimensional Fund Advisors held 17,710 shares of Aardvark Therapeutics worth $93.3K as of Q3 2026.
Aardvark Therapeutics was a new Dimensional Fund Advisors position in Q3 2026.
Aardvark Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #3139 holding.
23 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.